Biblio Discovery — Demo Discovery Service

142 results

Showing 1–20 · 2.60 seconds · RSS

Journal

Medical Cannabis and Cannabinoids, Pp 1-25 (2026)

Scopus

ISSN 2504-3889 · Karger Publishers · 142 articles in the index

  1. Journal Article

    Cannabis Use Documentation within the Electronic Health Record: A Use Case for Natural Language Processing Methods

    Apoorva M. Pradhan; Vishal A. Shetty; Christina M. Gregor et al.

    Medical Cannabis and Cannabinoids, Pp 1-25 (2026) · 2026 · English · DOAJ Scopus

    Introduction: Recreational and medical cannabis use (CU) information is often available within the electronic health record (EHR) in a format that is impractical for health care provider use. Transformation of free-text EHR documentation in notes to discrete elements is possible using natural…

  2. Journal Article

    Marijuana Use for Symptom Control in Inflammatory Bowel Disease: Patients’ Perceptions and Patterns of Use

    Arvin Daneshmand; Karen Yung; Hanzhi Gao et al.

    Medical Cannabis and Cannabinoids, Pp 1-18 (2026) · 2026 · English · DOAJ Scopus

    Many patients with Inflammatory Bowel Disease (IBD) use marijuana for disease-related symptoms. Data regarding reasons for usage, impact, and perceptions on its effects is lacking. Our study aims to understand patterns of marijuana use, underlying symptom response, and beliefs about marijuana in…

  3. Journal Article

    Oral Cannabidiol in the Treatment of Myofascial Pain Disorder of the Temporomandibular Region: A Placebo-Controlled Randomized Clinical Trial

    Gwendolyn S. Reeve; Rachel B. Kutler; Adam Abel et al.

    Medical Cannabis and Cannabinoids, Vol. 9 No. 1 · 2026 · English · DOAJ Scopus

    Introduction: The efficacy of oral cannabidiol (CBD) for the management of myofascial pain disorder (MPD) of the temporomandibular region remains understudied. Therefore, the purpose of this study was to determine whether cannabinoids provide pain relief and improve jaw function in patients with…

  4. Journal Article

    Quantitative Analysis of Cannabinoid Therapy in Prostate Cancer: Integrating Biomarkers, Imaging, and Patient Outcomes

    Shiksha Gallow; Ashley Hilton Adrian Ross; Brenda Thabisile Mkhize et al.

    Medical Cannabis and Cannabinoids, Vol. 9 No. 1 · 2026 · English · DOAJ Scopus

    Introduction: Cannabinoids are increasingly used by cancer patients for symptom relief, yet clinical evidence on their effect in prostate cancer remains limited. This study evaluated the association between cannabinoid therapy and disease activity, pain, and quality of life in men with prostate…

  5. Journal Article

    Steroid Hormone Changes after Short-Term High-Dose Exposure to Cannabidiol in Healthy Subjects: An Exploratory Study

    Qingchen Zhang; Christopher A. Singleton; Philip W. Melchert et al.

    Medical Cannabis and Cannabinoids, Vol. 9 No. 1 · 2026 · English · DOAJ Scopus

    Introduction: Cannabis-derived cannabidiol (CBD; Epidiolex®) is FDA-approved for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex, yet its effects on human steroid hormone regulation remain unclear. This study evaluated changes in five plasma steroid…

  6. Journal Article

    Targeting Phantom Limb Pain with Cannabinoids in a Rat Model

    Anjalika Eeswara; Kristin Perrucci; Stanislava Jergova et al.

    Medical Cannabis and Cannabinoids, Vol. 9 No. 1 · 2026 · English · DOAJ Scopus

    Introduction: Phantom limb pain (PLP) is a debilitating neuropathic condition arising after limb loss or nerve injury, with limited effective treatments. Cannabinoids, including cannabidiol (CBD), β-caryophyllene (BCP), and Δ9-tetrahydrocannabinol (THC), possess analgesic and anti-inflammatory…

  7. Journal Article

    Pharmacokinetics of Cannabinoids Delivered by Diverse Routes in Rodents

    Shivani S. Godbole; Wesley M. Raup-Konsavage; Kent E. Vrana

    Medical Cannabis and Cannabinoids, Vol. 9 No. 1 · 2026 · English · DOAJ Scopus

    Background: The rising popularity of medicinal and recreational use of Cannabis sativa L. has prompted a parallel increase in the number of studies administering the plant and extracts of its constituent compounds to animal models. Typical routes of administration of Cannabis to animals differ from…

  8. Journal Article

    The Persistence of Stigma and Other Challenges Experienced by Medical Cannabis Users: A Thematic Synthesis of Qualitative Studies

    Martina Breuning; Jason Nie; Mark Schlesinger et al.

    Medical Cannabis and Cannabinoids, Vol. 9 No. 1 · 2026 · English · DOAJ Scopus

    Background: The legislation, practices, and guidance shaping patient and professional access to medical cannabis (MC) for managing chronic pain and other conditions vary widely across jurisdictions. Despite promising evidence of effectiveness, challenges persist for those trying to access or…

  9. Journal Article

    Factors Associated with Possible Cannabis Use Disorder among Adults Using Medical Cannabis in Florida: A Cross-Sectional Study

    Robert L. Cook; Sophie Maloney; Hanzhi Gao et al.

    Medical Cannabis and Cannabinoids, Vol. 9 No. 1 · 2026 · English · DOAJ Scopus

    Introduction: The number of people using medical cannabis has increased in the United States, but little is known about the prevalence or risk factors for Cannabis Use Disorder (CUD) in this population. We sought to estimate the prevalence of CUD and to identify individual characteristics and…

  10. Journal Article

    Effect of Cannabigerol on Sleep and Quality of Life in Veterans: A Decentralized, Randomized, Placebo-Controlled Trial

    Chris R. Emerson; Courtney E. Webster; Eric J. Daza et al.

    Medical Cannabis and Cannabinoids, Vol. 9 No. 1 · 2025 · English · DOAJ Scopus

    Introduction: This decentralized, randomized, triple-blind, placebo-controlled study evaluated efficacy and safety of oral cannabigerol (CBG) in Veterans with sleep issues. Methods: After a 2-week run-in phase, participants received CBG (25 mg daily for 2 weeks, then 50 mg daily for a further 2…

  11. Journal Article

    A Randomized, Single-Dose, Single-Sequence, Two-Arm (Fasting and Fed), Open-Label Study on the Oral Pharmacokinetics of a Nanodispersible Cannabidiol Solution (150 mg/mL)

    Prasad Rao Gundugurti; Monila Nadikudi; Ramyasree Thatikonda et al.

    Medical Cannabis and Cannabinoids, Vol. 9 No. 1 · 2025 · English · DOAJ Scopus

    Introduction: Cannabidiol (CBD), a non-psychoactive phytocannabinoid, attributed to its therapeutic benefits and positive safety profile is being studied for its potential to treat various medical conditions. The low oral bioavailability and significant first-pass metabolism present pharmacokinetic…

  12. Journal Article

    The Individual and Interactive Effects of Alpha-Pinene and Delta-9-Tetrahydrocannabinol in Healthy Adults

    Lakshmi Kumar; Tory R. Spindle; C. Austin Zamarripa et al.

    Medical Cannabis and Cannabinoids, Vol. 8 No. 1 · 2025 · English · DOAJ Scopus

    Introduction: Cannabis contains hundreds of chemical constituents beyond delta-9-tetrahydrocannabinol (Δ9-THC), which is thought to be the primary driver of most of its acute pharmacodynamic effects. The entourage effect theory asserts that the pharmacological and therapeutic effects of cannabis…

  13. Journal Article

    Cannabis Certifications for Severe Chronic and Intractable Pain: Geographic Patterns across Pennsylvania, USA

    Sanya K. Mehta; Lorraine D. Tusing; Ahmad Higazy et al.

    Medical Cannabis and Cannabinoids, Vol. 8 No. 1 · 2025 · English · DOAJ Scopus

    Introduction: Chronic pain is the most common qualifying condition found in states with legal (certified) access to medical cannabis (MC). We assessed the geographic distribution of MC certifications for severe chronic or intractable pain in Pennsylvania (PA) between 2018 and 2024, identifying…

  14. Journal Article

    Medical Patients’ Awareness, Perspectives, and Experiences with Contaminated Cannabis

    Gabriel Spandau; Jamie Loizzo; Amie Goodin et al.

    Medical Cannabis and Cannabinoids, Vol. 8 No. 1 · 2025 · English · DOAJ Scopus

    Introduction: Concerns about contamination in medical cannabis products have garnered media attention, but there is limited evidence in the literature documenting patient and consumer experiences. With growing public interest in medical cannabis and potential health hazards associated with…

  15. Journal Article

    Cannabinoids for Anxiety and Sleep Disturbances: A Scoping Review

    Juan G. Perez; Liva G. LaMontagne; Gabriela A. Garcia et al.

    Medical Cannabis and Cannabinoids, Vol. 8 No. 1 · 2025 · English · DOAJ Scopus

    Background: At least 60% of individuals with anxiety disorders report sleep disturbances, which might be explained by shared physiological mechanisms, including cortisol dysregulation and executive function skills disruption. The scientific literature regarding medical cannabis as a potential…

  16. Journal Article

    UK Medical Cannabis Registry: An Updated Analysis of Cannabis-Based Medicinal Products for Multiple Sclerosis

    Yashvi Shah; Simon Erridge; Evonne Clarke et al.

    Medical Cannabis and Cannabinoids, Vol. 8 No. 1 · 2025 · English · DOAJ Scopus

    Introduction: Multiple sclerosis (MS) is a neurodegenerative disease presenting with a wide range of motor, sensory, and psychiatric symptoms. Although nabiximols is licensed for MS-induced spasticity, cannabis-based medicinal products (CBMPs) have also displayed promising therapeutic potential for…

  17. Journal Article

    Public Attitudes Toward the Drug Enforcement Administration’s Proposal to Reschedule Marijuana: A Cross-Sectional Mixed-Methods Analysis

    Rebecca H. Lucas; Anna Nahirnyak; Jamie Piliero et al.

    Medical Cannabis and Cannabinoids, Vol. 8 No. 1 · 2025 · English · DOAJ Scopus

    Introduction: On May 21, 2024, the Drug Enforcement Administration (DEA) published a proposed rule to reschedule marijuana from schedule I to III under the Controlled Substance Act (CSA), followed by a 60-day open comment period. The purpose of this study was to analyze the public attitudes…

  18. Journal Article

    Chewing Gum as a Delivery System for Cannabidiol: A Commentary

    Peter Pressman; A. Wallace Hayes; Ahmed M. Hamam et al.

    Medical Cannabis and Cannabinoids, Vol. 8 No. 1 · 2025 · English · DOAJ Scopus

    Background: Despite significant gaps in the research literature, the integration of cannabidiols into chewing gum as a drug delivery system is a novel and promising approach for various cannabinoid therapeutic applications. Chewing gum offers a unique delivery mechanism that may promote both local…

  19. Journal Article

    Perception of Risks of Cannabis and Cannabidiol Use during Pregnancy: A Multi-Methods Study

    Amie Goodin; Deepthi S. Varma; Karamveer Dhillon et al.

    Medical Cannabis and Cannabinoids, Vol. 8 No. 1 · 2025 · English · DOAJ Scopus

    Introduction: The American College of Obstetrics and Gynecology advises against cannabis and cannabidiol (CBD) product use during pregnancy; despite this, recent studies suggest cannabis and CBD use is increasing during pregnancy. The objective of this study is to assess risk perceptions of…